Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
- PMID: 28376239
- DOI: 10.1002/acr.23249
Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Abstract
Objective: To characterize psoriatic arthritis (PsA) patients with dactylitis or enthesitis and evaluate the associations of these manifestations with disease activity and patient-reported outcomes.
Methods: Using the Corrona PsA/Spondyloarthritis Registry, patient characteristics, disease activity, and patient-reported outcomes at registry enrollment were assessed for PsA patients ages ≥18 years with or without dactylitis or enthesitis. Regression models were used to evaluate associations of dactylitis and enthesitis with outcomes, including minimal disease activity, Health Assessment Questionnaire scores, patient-reported pain and fatigue, and work productivity (Work Productivity and Activity Impairment questionnaire). Adjustments were made for age, sex, race, body mass index, disease duration, and history of biologic agent, disease-modifying antirheumatic drug, and prednisone use.
Results: This analysis included 1,567 PsA patients (420 with enthesitis; 228 with dactylitis). Patients with versus without dactylitis or enthesitis had greater disease activity and were less likely to be in minimal disease activity (P < 0.05). Patients with versus without enthesitis had poorer functional status as assessed by the Health Assessment Questionnaire (adjusted P = 4.15 x 10-5 ), greater patient-reported pain and fatigue (adjusted P < 0.0001), and greater likelihood of any impairment while working (adjusted odds ratio [OR] 1.57, P = 0.027), overall work impairment (OR 1.85, P = 0.006), and activity impairment (OR 1.77, P = 0.008). Dactylitis was associated with similar numerical trends, but differences versus patients without dactylitis did not reach statistical significance.
Conclusion: Enthesitis and dactylitis are associated with greater overall disease burden of PsA, underscoring the importance of identifying, assessing, and effectively managing these periarticular manifestations.
© 2017, American College of Rheumatology.
Similar articles
-
Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry.J Rheumatol. 2017 Aug;44(8):1151-1158. doi: 10.3899/jrheum.160963. Epub 2017 Jun 15. J Rheumatol. 2017. PMID: 28620063
-
Clinical Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort: Incidence, Prevalence, Characteristics, and Outcome.Arthritis Care Res (Hoboken). 2017 Nov;69(11):1685-1691. doi: 10.1002/acr.23174. Epub 2017 Sep 21. Arthritis Care Res (Hoboken). 2017. PMID: 27998023
-
Active peripheral inflammation is associated with pro-atherogenic lipid profile in psoriatic arthritis.Semin Arthritis Rheum. 2016 Dec;46(3):286-290. doi: 10.1016/j.semarthrit.2016.05.011. Epub 2016 Jun 2. Semin Arthritis Rheum. 2016. PMID: 27373499
-
Enthesitis and Dactylitis in Psoriatic Disease: A Guide for Dermatologists.Am J Clin Dermatol. 2018 Dec;19(6):839-852. doi: 10.1007/s40257-018-0377-2. Am J Clin Dermatol. 2018. PMID: 30117018 Free PMC article. Review.
-
Treatment of Dactylitis and Enthesitis in Psoriatic Arthritis with Biologic Agents: A Systematic Review and Metaanalysis.J Rheumatol. 2020 Jan;47(1):59-65. doi: 10.3899/jrheum.180797. Epub 2019 Mar 1. J Rheumatol. 2020. PMID: 30824641
Cited by
-
A paradigm shift in studies based on rheumatoid arthritis clinical registries.Korean J Intern Med. 2019 Sep;34(5):974-981. doi: 10.3904/kjim.2018.440. Epub 2019 Feb 18. Korean J Intern Med. 2019. PMID: 30759964 Free PMC article. Review.
-
Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trials.Rheumatology (Oxford). 2024 Nov 1;63(11):3146-3154. doi: 10.1093/rheumatology/keae057. Rheumatology (Oxford). 2024. PMID: 38331400 Free PMC article. Clinical Trial.
-
Physical component of SF-36 is associated with measures of disease activity in patients with psoriatic arthritis: a real-life study from a tertiary referral centre.Rheumatol Int. 2024 Dec;44(12):2897-2904. doi: 10.1007/s00296-024-05727-w. Epub 2024 Oct 10. Rheumatol Int. 2024. PMID: 39384567
-
Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions.Arch Rheumatol. 2018 May 21;33(2):108-127. doi: 10.5606/ArchRheumatol.2018.6946. eCollection 2018 Jun. Arch Rheumatol. 2018. PMID: 30207576 Free PMC article.
-
Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies.Arthritis Res Ther. 2023 Aug 22;25(1):153. doi: 10.1186/s13075-023-03108-5. Arthritis Res Ther. 2023. PMID: 37608391 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous